CoreyJLangerMD

Oncology • Philadelphia, PA

Head & Neck Cancer, Hematologic Oncology, Thoracic Cancer

Director of Thoracic Oncology

Join to view full profile

Dr. Langer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Langer's full profile

Already have an account?

Office
3400 Civic Center Blvd
Fl 3
Philadelphia, PA 19104
Phone+1 215-615-5858

Fax+1 215-615-3349

Education & Training

Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 1986 - 1987
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1984 - 1986
Graduate HospitalResidency, Internal Medicine, 1981 - 1984
Boston University School of MedicineClass of 1981

Certifications & Licensure

PA State Medical License 1982 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Philadelphia Magazine Castle Connolly, 2004-2014
America's Top Doctors Castle Connolly, 2002-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FACP) American College of Physicians, 1996
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Paclitaxel in Treating Patients With Advanced Head and Neck Cancer Start of enrollment: 1997 Feb 21
Completed
Phase 2
Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma Start of enrollment: 1996 Aug 01
Completed
Phase 1
Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer Start of enrollment: 1997 Oct 01
Completed
Phase 2
Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer Start of enrollment: 1999 Apr 22
Completed
Phase 3
Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer Start of enrollment: 1999 May 01
Completed
Phase 2
S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer Start of enrollment: 1999 Oct 01
Completed
Phase 3
Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma Start of enrollment: 1996 Jul 01
Completed
Phase 1
Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer Start of enrollment: 2000 Jan 01
Completed
Phase 2
Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer Start of enrollment: 2000 Mar 01
Completed
Phase 2
Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer Start of enrollment: 2000 Aug 22
Completed
Phase 2
Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer Start of enrollment: 1999 Sep 01
Completed
Phase 2
Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors Start of enrollment: 1997 Nov 01
Completed
Phase 1
Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer Start of enrollment: 1999 Jan 01
Completed
Phase 1
Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer Start of enrollment: 2002 Jan 01
Completed
Phase 2
Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Start of enrollment: 2003 Mar 01
Completed
Phase 1
Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2005 Apr 08
Completed
Phase 2
Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer Start of enrollment: 2004 Dec 01
Completed
Phase 2
A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC) Start of enrollment: 2006 Jul 01
Completed
Phase 2
Trial of Poor Performance Status Patients (ToPPS) Start of enrollment: 2009 Jun 01
Completed
Phase 2
Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck Start of enrollment: 2009 Oct 01
Completed
Phase 2
Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC) Start of enrollment: 2010 Jul 01
Completed
Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer Start of enrollment: 2011 Jan 11
Terminated
Phase 3
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM) Start of enrollment: 2023 Jan 10
Recruiting
Phase 1
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy.
Omar Elghawy, Adam Barsouk, Lauren Reed-Guy, Margaret Stalker, Jonathan Sussman
Clinical Lung Cancer. 2024-12-13
Calls to action on lung cancer management and research.
May-Lucie Meyer, Fred R Hirsch, Paul A Bunn, Peter Ujhazy, David Fredrickson
The Oncologist. 2024-12-06
Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From ...
Melina E Marmarelis, Dylan G Scholes, Tara L McWilliams, Wei-Ting Hwang, John Kosteva
JCO Oncology Practice. 2024-12-01

Journal Articles

Cisplatin Versus Cetuximab with Definitive Concurrent Radiotherapy for Head and Neck Squamous Cell Carcinoma: An Analysis of Veterans Health Affairs Data
Ravi Vinnakota, Keith Sigel, Joshua M Bauml, Roger B Cohen, Nevena Damjanov, Corey J Langer, Ronac Mamtani, Charu Aggarwal, Christina Knepley, Juan Wisnivesky, Cancer
Predictive Biomarkers for Response to EGFR-Directed Monoclonal Antibodies for Advanced Squamous Cell Lung Cancer
D R Spigel, E S Kim, S S Ramalingam, M A Socinski, C Obasaju, C J Langer, R B Natale, P D Bonomi, H Wakelee, Annals of Oncology
Thoracic Imaging of Non-Small Cell Lung Cancer Treated with Anti-Programmed Death Receptor-1 Therapy
Sharyn I Katz, Arun C Nachiappan, Joshua Bauml, Stephen Bagley, Charu Aggarwal, Corey Langer, ScienceDirect

Lectures

What’s the Role for Immunotherapy With and Without Chemotherapy in Oncogene Mutated NSCLC?
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
PD-L1, CTLA4, Cyclin D, Oh, My!
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
2013 Updates in Oncology
Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania - 6/25/2013
7th Community Oncology Conference
Global Academy for Medical Education (Elsevier), Las Vegas, Nevada - 3/30/2012
Join now to see all

Press Mentions

Party with a Purpose Benefits AACR and Supports Lung Cancer ResearchOctober 27th, 2022
Oncocyte Launches First Real-World Evidence (RWE) Registry to Evaluate Biomarker Impact on Early-Stage Lung Cancer Treatment Decisions and OutcomesAugust 17th, 2021
Novocure Announces FDA IDE Approval and Steering Committee for KEYNOTE-B36 Trial Evaluating Tumor Treating Fields Together with Pembrolizumab in Non-Small Cell Lung CancerApril 22nd, 2021
Join now to see all

Committees

Member, Definitive and Adjuvant Radiotherapy in Locally Advanced Non-small Cell Lung Cancer Guideline Panel, American Society for Radiation Oncology 2015 - Present